艾昆纬-抓住时机：生物技术自我商业化的黄金机遇-2026.pdfVIP

WhitePaper

SeizingtheMoment:Biotech’sGolden

OpportunityforSelf-Commercialisation

Leapfrogginglegacymodelstorealisethepromiseoflean,

technology-centriccommercialisation

MARKUSGORES,VicePresident,ThoughtLeadership,IQVIA

THOMASBAKER,SeniorVicePresident,GlobalData,Technology,andAdvisoryServices,IQVIA

CHARLESRINK,SeniorPrincipal,InformationManagementAnalyticsTechnology,IQVIA

MIKESANVOISIN,VicePresident,BiotechCommercialServices,IQVIA

Tableofcontents

Executivesummary1

Introduction2

Aneweraforcommercialisation3

AgoldenopportunityforEBPs:Leapfrogginglegacymodels6

Layingthefoundationofthenewmodel7

Moderndatamanagement:Thecorefoundationofthetechnology-enabledEBP8

Envisioningthedata-enabledEBPcommercialengine9

Thejourneytowardsatechnology-enabledcommercialmodel11

Full-serviceailiateoutsourcing13

IQVIAcapabilities:SupportingtheEBPself-commercialisationjourney16

Abouttheauthors18

Executivesummary

Healthsystemsareincreasinglyledbydigitallysavvydecisionmakerswho

expectfaster,morerelevant,andpersonalisedinformation.Alongsidetherise

ofagenticAIandenablingtechnologies,thistransformationininformation

requirementsisupendingtraditionalpharmaceuticalgotomarketmodelsby

fundamentallyrewritingtherulesofcommercialisation.

ForEmergingBiopharmaCompanies(EBPs)thiscreatescost,